{
    "Trade/Device Name(s)": [
        "eSensor\u00ae Warfarin Sensitivity Saliva Test"
    ],
    "Submitter Information": "GenMark Diagnostics, Incorporated",
    "510(k) Number": "K152612",
    "Predicate Device Reference 510(k) Number(s)": [
        "K110786"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "ODW",
        "ODV",
        "NSU"
    ],
    "Summary Letter Date": "April 21, 2016",
    "Summary Letter Received Date": "April 22, 2016",
    "Submission Date": "May 23, 2016",
    "Regulation Number(s)": [
        "21CFR862.3360",
        "21CFR864.7750",
        "21CFR862.2570"
    ],
    "Regulation Name(s)": [
        "Drug Metabolism Enzyme Genotyping Test",
        "Prothrombin Time Test",
        "Instrumentation for clinical multiplex test systems"
    ],
    "Analyte Class(es)": [
        "genetic molecular",
        "hematology"
    ],
    "Analyte(s)": [
        "CYP450 2C9 *2 allele",
        "CYP450 2C9 *3 allele",
        "VKORC1 -1639G>A polymorphism"
    ],
    "Specimen Type(s)": [
        "Saliva"
    ],
    "Specimen Container(s)": [
        "Oragene\u00ae\u2022Dx device",
        "ORAcollect\u00ae\u00b7Dx device"
    ],
    "Instrument(s)/Platform(s)": [
        "eSensor\u00ae XT-8 System"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical detection",
        "PCR",
        "DNA amplification",
        "Hybridization"
    ],
    "Methodologies": [
        "Genotyping",
        "DNA extraction"
    ],
    "Submission Type(s)": [
        "Test",
        "Kit",
        "Cartridge",
        "Amplification reagents",
        "Detection reagents",
        "Instrument",
        "Specimen collection device"
    ],
    "Document Summary": "FDA 510(k) summary for eSensor Warfarin Sensitivity Saliva Test for genotyping CYP2C9 and VKORC1 polymorphisms from saliva using the eSensor XT-8 System",
    "Indications for Use Summary": "In vitro diagnostic for detection and genotyping of CYP2C9 *2 and *3 alleles and VKORC1 -1639G>A promoter polymorphism from genomic DNA extracted from human saliva as an aid in identification of patients at risk for increased warfarin sensitivity",
    "fda_folder": "Toxicology"
}